FDA Approves First Gene Therapy, Kymriah, for Use in U.S.

WEDNESDAY, Aug. 30, 2017 -- The U.S. Food and Drug Administration broke new ground in cancer care Wednesday by approving the first gene therapy for patients in the United States. Kymriah (tisagenlecleucel) genetically tweaks a patient ' s own immune...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news